TH-1 and TH-2 Cytokines in stable chronic alcoholics

Alcohol and Alcoholism

Volumn 47, Issue 4, 2012, Pages 390-396

  Gonzalez Reimers E ^a   Santolaria Fernandez F ^a   Medina Garcia J A ^a   Gonzalez Perez J M ^a   de la Vega Prieto, M J ^a   Martin Gonzalez L ^a   Duran Castellon M C ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; LIVER FUNCTION; MORTALITY; NUTRITIONAL STATUS; PRIORITY JOURNAL; SURVIVAL; TH1 CELL; TH2 CELL; THEOPHYLLINE BLOOD LEVEL;

ADULT; ALCOHOLISM; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; NUTRITION ASSESSMENT; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

NEGIBACTERIA;

EID: 84864005556     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/ags041     Document Type: Article

References (48)

1. Albano E. (2012) Role of adaptative immunity in alcoholic liver disease. Int J Hepatol doi:10.1155/2012/893026
2. Albano E, Vidali M. (2010) Immune mechanisms in alcoholic liver disease. Genes Nutr 5:141-7.
3. Bird GL, Sheron N, Goka AK et al. (1990) Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 112:917-20.
4. Blackburn GL, Bistrian BR, Maini BS et al. (1977) Nutritional and meatbolic assessment of the hospitalized patient. J Parenter Enteral Nutr 1:11-22.
5. Chiaramonte MG, Donaldson DD, Cheever AW et al. (1999) An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 104:777-85.
6. Cihakova D, Barin JG, Afanasyeva, M et al. (2008) Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am J Pathol 172:1195-208.
7. Commins S, Steinke JW, Borish L. (2008) The extended IL-10 superfamily: Il-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 121:1108-11.
8. Crews FT, Bechara R, Brown LA et al. (2006) Cytokines and alcohol. Alcohol Clin Exp Res 30:720-30.
9. Daniluk J, Szuster-Ciesielska A, Drabko, J et al. (2001) Serum cytokine levels in alcohol-related liver cirrhosis. Alcohol 23:29-34.
10. Das SK, Mukherjee S, Gupta, G et al. (2010) Protective effect of resveratrol and vitamin E against ethanol-induced oxidative damage in mice: biochemical and immunological basis. Indian J Biochem Biophys 47:32-7.
11. Domínguez-Santalla MJ, Vidal C, Viñuela, J et al. (2001) Increased serum IgE in alcoholics: relationship with Th1/Th2 cytokine production by stimulated blood mononuclear cells. Alcohol Clin Exp Res 25:1198-205.
12. Fallon PG, Richardson EJ, McKenzie GJ et al. (2000) Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: Il-13 is a profibrotic agent. J Immunol 164:2585-91.
13. Fujimoto M, Uemura M, Nakatani, Y et al. (2000) Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol Clin Exp Res 24:48S-54.
14. Fukui H. (2005) Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure. Alcohol Clin Exp Res 29(11 suppl):172S-9.
15. González-Quintela A, Vidal C, Lojo, S et al. (1999) Serum cytokines and increased total serum IgE in alcoholics. Ann Allergy Asthma Immunol 83:61-7.
16. González-Quintela A, Domínguez-Santalla MJ, Pérez LF et al. (2000) Influence of acute alcohol intake and alcohol withdrawal on circulating levels of IL-6, IL-8, IL-10 and IL-12. Cytokine 12:1437-40.
17. González-Reimers E, Sánchez-Pérez MJ, Santolaria-Fernández, F et al. (2012) Changes in cytokine levels during admission and mortality in acute alcoholic hepatitis. Alcohol, http://dx.doi.org/ 10.1016/j.alcohol.2011.10.001.
18. Hernández-Plasencia D, Santolaria-Fernández F, Hernández-García, M et al. (1991) Subjective nutritional assessment and short-term prognosis. J Nutr Environ Med 2:151-62.
19. Hershey GKK. (2003) IL-13 receptors and signalling pathways: an evolving web. J Allergy Clin Immunol 111:677-90.
20. Huang YS, Chan CY, Wu JC et al. (1996) Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol 24:377-84.
21. Infante-Rivard C, Esnaola S, Villeneuve JP. (1987) Clinical and statistical validity of convencional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 7:660-4.
22. Jarque-López A, González-Reimers E, Rodríguez-Moreno, F et al. (2001) Prevalence and mortality of heavy drinkers in a general Medical Hospital Unit. Alcohol Alcohol 36:335-8.
23. Laso FJ, Iglesias MC, López, A et al. (1998) Increased interleukin-12 serum levels in chronic alcoholism. J Hepatol 28:771-7.
24. Laso FJ, Iglesias-Osma C, Ciudad, J et al. (1999) Chronic alcoholism is associated with an imbalanced production of Th-1/Th-2 cytokines by peripheral blood T cells. Alcohol Clin Exp Res 23:1306-11.
25. Laso FJ, Pastor I, Orfao A. (2005) Sistema immune y enfermedad hepática por alcohol. Med Clin (Barc) 125:263-9.
26. Latvala J, Hietala J, Koivisto, H et al. (2005) Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease. Am J Gastroenterol 100:1303-10.
27. Lohman TG. (1996) Dual energy X-ray absorptiometry. In Roche AF, Heymsfield SB, Lohman TG (eds). Human Body Composition. Champaign, USA: Human Kinetics, 63-78.
28. McCLain CJ, Song Z, Barve SS et al. (2004) Recent advances in alcoholic liver disease IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol 287:G497-503.
29. Mitchell PO, Jensen JS, Ritzenthaler JD et al. (2009) Alcohol primes the airway for increased interleukin-13 signaling. Alcohol Clin Exp Res 33:505-13.
30. Morimoto S, Tokano Y, Kaneko, H et al. (2001) The increased interleukin-13 in patients with systemic lupus erythematosus: relations to other Th1-, Th2-related cytokines and clinical findings. Autoimmunity 34:19-25.
31. Mosser DM, Zhang X. (2008) Activation of murine macrophages. Curr Protoc Immunol doi:10.1002/0471142735.im1402s83.
32. Nanji AA, Jokelainen K, Rahemtulla, A et al. (1999) Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 30:934-43.
33. Naveau S, Abella A, Raynard, B et al. (2001) Tumor necrosis factor soluble receptor p55 and lipid peroxidation in patients with acute alcoholic hepatitis. Am J Gastroenterol 96:3361-7.
34. Naveau S, Balian A, Capron, F et al. (2005) Balance between pro and anti-inflammatory cytokines in patients with acute alcoholic hepatitis. Gastroenterol Clin Biol 29:269-74.
35. Nicolaou C, Chatzipanagiotou S, Tzivos, D et al. (2004) Serum cytokine concentrations in alcohol-dependent individuals without liver disease. Alcohol 32:243-7.
36. Oliphant CJ, Barlow JL, McKenzie ANJ. (2011) Insights into the initiation of type 2 immune responses. Immunology 134:378-85.
37. Rodríguez-Rodríguez E, González-Reimers E, Santolaria-Fernández, F et al. (1995) Cytokine levels in acute alcoholic hepatitis: a sequential study. Drug Alcohol Depend 39:23-7.
38. Ronis MJJ, Butura A, Korourian, S et al. (2008) Cytokine and chemokine expression associated with steatohepatitis and hepatocyte proliferation in rats fed ethanol via total enteral nutrition. Exp Biol Med 233:344-55.
39. Sander M, Irwin M, Sinha P et al. (2002) Suppression of interleukin-6 to interleukin-10 ratio in chronic alcoholics: association with postoperative infections. Intensive Care Med 28:285-92.
40. Shimamura T, Fujisawa T, Husain SR et al. (2008) Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model. J Immunol 181:4656-65.
41. Song C, Lin A, De Jong R et al. (1999) Cytokines in detoxified patients with chronic alcoholism without liver disease: increased monocytic cytokine production. Biol Psychiatry 45:1212-6.
42. Starkenburg S, Munroe ME, Waltenbaugh C. (2001) Early alteration in leukocyte populations and Th1/Th2 function in ethanolconsuming mice. Alcohol Clin Exp Res 25:1221-30.
43. Su GL, Goyert SM, Fan MH et al. (2002) Activation of human and mouse Kupffer cells by lipopolysaccaride is mediated by CD14. Am J Physiol 283:G640-5.
44. Vergani D, Mieli-Vergani G. (2008) Aetiopathogenesis of autoimmune hepatitis. World J Gastroenterol 14:3306-12.
45. Viitala K, Israel Y, Blake JE et al. (1997) Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption. Hepatology 25:1418-24.
46. Weng HL, Liu Y, Chen JL et al. (2009) The etiology of liver damage imparts cytokines transforming growth factor beta-1 or interleukin-13 as driving forces in fibrogenesis. Hepatology 50:230-43.
47. Wynn TA. (2004) Fibrotic disease and the Th1/Th2 paradigm. Nat Rev Immunol 4:583-94.
48. Yin M, Wheeler MD, Kono, H et al. (1999) Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117:942-52.